Arcus Biosciences Inc (RCUS)
Operating return on assets (Operating ROA)
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating income (ttm) | US$ in thousands | -330,000 | -318,000 | -293,000 | -270,000 | -340,000 | -323,000 | -313,000 | -299,000 | -280,000 | 75,019 | 66,883 | 59,747 | 54,000 | -278,796 | -199,108 | -168,347 | -124,000 | -89,750 | -114,551 | -98,336 |
| Total assets | US$ in thousands | 1,150,000 | 1,252,000 | 1,186,000 | 1,293,000 | 1,095,000 | 1,191,000 | 1,220,000 | 1,254,000 | 1,345,000 | 1,393,820 | 1,476,770 | 1,543,430 | 1,592,000 | 839,290 | 898,773 | 935,119 | 772,292 | 811,075 | 481,389 | 176,144 |
| Operating ROA | -28.70% | -25.40% | -24.70% | -20.88% | -31.05% | -27.12% | -25.66% | -23.84% | -20.82% | 5.38% | 4.53% | 3.87% | 3.39% | -33.22% | -22.15% | -18.00% | -16.06% | -11.07% | -23.80% | -55.83% |
December 31, 2024 calculation
Operating ROA = Operating income (ttm) ÷ Total assets
= $-330,000K ÷ $1,150,000K
= -28.70%
Arcus Biosciences Inc's operating return on assets (ROA) has shown fluctuating trends over the analyzed period. The company experienced negative operating ROA figures initially, with values as low as -55.83% in March 2020, indicating inefficiency in generating operating profits relative to its assets.
There was a slight improvement in the operating ROA figures in the subsequent quarters of 2020 and 2021, though still negative. The situation changed positively in December 2021, where the company achieved a positive operating ROA of 3.39%, signaling a turnaround in profitability relative to its assets.
This positive trend continued in the following quarters of 2022, reaching the highest point of 5.38% in September 2022. However, the operating ROA declined significantly in the subsequent periods, dropping back into negative territory by December 2022.
The negative trend persisted into 2024, with operating ROA figures fluctuating in the negative range, indicating challenges in efficiently utilizing assets to generate profits. Overall, Arcus Biosciences Inc's operating ROA shows a mix of positive and negative performance trends, suggesting the company's varying effectiveness in generating operating income relative to its assets.
Peer comparison
Dec 31, 2024